1 |
10-mg dose of e5501 2g tablet |
- |
- |
- |
- |
063 1件: 63 💬 |
2 |
10-mg dose of e5501 cyclodextrin oral solution |
- |
- |
- |
- |
063 1件: 63 💬 |
3 |
10-mg dose of e5501 lipid-based oral |
- |
- |
- |
- |
063 1件: 63 💬 |
4 |
10-mg dose of e5501-p21% powder |
- |
- |
- |
- |
063 1件: 63 💬 |
5 |
[ucb7665 ] |
- |
- |
- |
- |
063 1件: 63 💬 |
6 |
Akr-501, ym-477 |
- |
- |
- |
- |
063 1件: 63 💬 |
7 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
8 |
Alemtuzumab, rituximab |
Alemtuzumab |
2件: D02802 D02802, D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
063 1件: 63 💬 |
9 |
All-trans retinoid acid(atra) |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
063 1件: 63 💬 |
10 |
Amg 531 |
- |
- |
- |
- |
063 1件: 63 💬 |
11 |
Amg531 |
- |
- |
- |
- |
060 2件: 60, 63 💬 |
12 |
Aminophylline |
Aminophylline |
2件: D00227 D00227, D05429 D05429 💬 |
ADORA1 18件: ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
Alcoholism 23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
063 1件: 63 💬 |
13 |
Amoxicillin |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 7件: 6 , 46, 63, 96, 97, 222, 299 💬 |
14 |
Amoxicillin hydrate |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
063 1件: 63 💬 |
15 |
Amoxycillin |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
063 1件: 63 💬 |
16 |
Anti-cd40l |
Toralizumab |
1件: D06193 D06193 💬 |
CD40LG 1件: CD40LG 💬 |
Allograft rejection 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis |
063 1件: 63 💬 |
17 |
Anti-cd40ldab |
- |
- |
- |
- |
063 1件: 63 💬 |
18 |
Anti-d |
- |
- |
- |
- |
063 1件: 63 💬 |
19 |
Argx-113 |
- |
- |
- |
- |
011 4件: 11, 14, 35, 63 💬 |
20 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
21 |
Atorvastatin 10mg |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
063 1件: 63 💬 |
22 |
Atorvastatin 20mg |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
063 1件: 63 💬 |
23 |
Atra |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
063 2件: 63, 94 💬 |
24 |
Avatrombopag |
Avatrombopag |
1件: D10306 D10306 💬 |
- |
- |
063 1件: 63 💬 |
25 |
Avatrombopag (proposed) |
Avatrombopag |
1件: D10306 D10306 💬 |
- |
- |
063 1件: 63 💬 |
26 |
Avatrombopag maleate |
Avatrombopag |
1件: D10306 D10306 💬 |
- |
- |
063 1件: 63 💬 |
27 |
Avatrombopag tablets |
Avatrombopag |
1件: D10306 D10306 💬 |
- |
- |
063 1件: 63 💬 |
28 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
29 |
Blinded (avatrombopoag tablets) |
- |
- |
- |
- |
063 1件: 63 💬 |
30 |
Blisibimod |
Blisibimod |
1件: D10311 D10311 💬 |
- |
- |
043 5件: 43, 44, 49, 63, 66 💬 |
31 |
Bms-986004 |
- |
- |
- |
- |
063 1件: 63 💬 |
32 |
Bms-986004 1500 mg iv |
- |
- |
- |
- |
063 1件: 63 💬 |
33 |
Bms-986004 225 mg iv |
- |
- |
- |
- |
063 1件: 63 💬 |
34 |
Bms-986004 675 mg iv |
- |
- |
- |
- |
063 1件: 63 💬 |
35 |
Bms-986004 75 mg iv |
- |
- |
- |
- |
063 1件: 63 💬 |
36 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
37 |
Bt595 |
- |
- |
- |
- |
063 2件: 63, 65 💬 |
38 |
Caffeic acid tablets |
- |
- |
- |
- |
063 1件: 63 💬 |
39 |
Clarithromycin |
Clarithromycin |
1件: D00276 D00276 💬 |
- |
- |
006 8件: 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
40 |
Conventional |
- |
- |
- |
- |
063 1件: 63 💬 |
41 |
Corticosteroids (aprednislon) |
- |
- |
- |
- |
063 1件: 63 💬 |
42 |
Csa |
- |
- |
- |
- |
019 8件: 19, 49, 50, 53, 60, 63, 222, 228 💬 |
43 |
Cyclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
44 |
Cyclosporin a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
45 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
46 |
Danazol |
Danazol |
1件: D00289 D00289 💬 |
AR 3件: AR, ESR1, PGR 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
060 5件: 60, 63, 64, 65, 285 💬 |
47 |
Daratumumab |
Daratumumab |
1件: D10777 D10777 💬 |
CD38 1件: CD38 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
016 4件: 16, 28, 63, 222 💬 |
48 |
Decitabine |
Decitabine |
1件: D03665 D03665 💬 |
DNMT1 3件: DNMT1, DNMT3A, DNMT3B 💬 |
Cysteine and methionine metabolism 3件: Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer |
063 1件: 63 💬 |
49 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
50 |
Dexamethasone (1 cycle) |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
51 |
Dexamethasone (4 cycles) |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
52 |
Dexamethasone abcur |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
53 |
Dexamethasone and rituximab |
Dexamethasone |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994 💬 |
MS4A1 2件: MS4A1, NR3C1 💬 |
Hematopoietic cell lineage 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
54 |
Doptelet |
- |
- |
- |
- |
063 1件: 63 💬 |
55 |
Doptelet 20 mg film-coated tablets |
- |
- |
- |
- |
063 1件: 63 💬 |
56 |
Doxil |
- |
- |
- |
- |
063 1件: 63 💬 |
57 |
E5501 |
- |
- |
- |
- |
063 1件: 63 💬 |
58 |
E5501 40 mg 2 x 20-mg tablets, orally, fasted |
- |
- |
- |
- |
063 1件: 63 💬 |
59 |
E5501 40 mg 2 x 20-mg tablets, orally, with food |
- |
- |
- |
- |
063 1件: 63 💬 |
60 |
E5501 40mg 2 x 20-mg tablets, orally, fasted |
- |
- |
- |
- |
063 1件: 63 💬 |
61 |
Efgartigimod |
- |
- |
- |
- |
011 3件: 11, 35, 63 💬 |
62 |
Efgartigimod alfa |
Efgartigimod alfa |
1件: D11876 D11876 💬 |
- |
- |
014 3件: 14, 35, 63 💬 |
63 |
Eltrombopag |
Eltrombopag |
1件: D03978 D03978 💬 |
- |
- |
060 5件: 60, 63, 65, 284, 285 💬 |
64 |
Eltrombopag (revolade) |
Eltrombopag |
1件: D03978 D03978 💬 |
- |
- |
063 1件: 63 💬 |
65 |
Eltrombopag combining rituximab |
Eltrombopag |
2件: D02994 D02994, D03978 D03978 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
063 1件: 63 💬 |
66 |
Eltrombopag olamine |
Eltrombopag |
1件: D03978 D03978 💬 |
- |
- |
060 2件: 60, 63 💬 |
67 |
Eltrombopag olamine (sb-497115-gr) |
Eltrombopag |
1件: D03978 D03978 💬 |
- |
- |
063 1件: 63 💬 |
68 |
Eltrombopag olamine, revolade, promacta |
Eltrombopag |
1件: D03978 D03978 💬 |
- |
- |
063 1件: 63 💬 |
69 |
Eltrombopag oral tablets |
Eltrombopag |
1件: D03978 D03978 💬 |
- |
- |
063 1件: 63 💬 |
70 |
Fcm |
- |
- |
- |
- |
063 2件: 63, 222 💬 |
71 |
Gammaplex |
- |
- |
- |
- |
063 2件: 63, 65 💬 |
72 |
Gammaplex, intravenous immunoglobulin |
- |
- |
- |
- |
063 1件: 63 💬 |
73 |
Glycyrrhetinic acid |
- |
- |
- |
- |
063 1件: 63 💬 |
74 |
Gma161 |
- |
- |
- |
- |
063 1件: 63 💬 |
75 |
Hbm9161 dose a |
- |
- |
- |
- |
063 1件: 63 💬 |
76 |
Hbm9161 dose b |
- |
- |
- |
- |
063 1件: 63 💬 |
77 |
Hetrombopag |
Hetrombopag |
- |
- |
- |
060 2件: 60, 63 💬 |
78 |
Hetrombopag olamine |
Hetrombopag |
- |
- |
- |
060 2件: 60, 63 💬 |
79 |
High dose dexamethasone pulses |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
80 |
Huaiqihuang granule |
- |
- |
- |
- |
063 1件: 63 💬 |
81 |
Human immunoglobulin |
- |
- |
- |
- |
063 2件: 63, 65 💬 |
82 |
Human immunoglobulin g |
Human immunoglobulin G |
- |
- |
- |
014 4件: 14, 50, 63, 65 💬 |
83 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
84 |
Human normal immunoglobulin (iv) |
Human immunoglobulin G |
- |
- |
- |
011 4件: 11, 14, 63, 65 💬 |
85 |
Human normal immunoglobulin for intravenous use |
Human immunoglobulin G |
- |
- |
- |
063 2件: 63, 65 💬 |
86 |
Human normal immunoglobulin for intrvenous use |
Human immunoglobulin G |
- |
- |
- |
063 1件: 63 💬 |
87 |
Human normal immunoglobulin g (igg > 98% purity) |
Human immunoglobulin G |
- |
- |
- |
014 3件: 14, 63, 65 💬 |
88 |
Humax-cd38 |
- |
- |
- |
- |
028 2件: 28, 63 💬 |
89 |
I10e |
- |
- |
- |
- |
014 3件: 14, 63, 65 💬 |
90 |
Ig vena |
- |
- |
- |
- |
050 2件: 50, 63 💬 |
91 |
Ig vena 100 ml vial |
- |
- |
- |
- |
063 1件: 63 💬 |
92 |
Ig vena 50 g/l solution for infusion 100 ml vial + infusion set |
- |
- |
- |
- |
063 2件: 63, 65 💬 |
93 |
Igg next generation |
- |
- |
- |
- |
063 2件: 63, 65 💬 |
94 |
Igiv3i grifols 10% |
- |
- |
- |
- |
063 1件: 63 💬 |
95 |
Ignextgen 10% |
- |
- |
- |
- |
063 1件: 63 💬 |
96 |
Immune globulin intravenous (human), 10% triple virally reduced solution |
- |
- |
- |
- |
063 1件: 63 💬 |
97 |
Immunglobulin |
- |
- |
- |
- |
063 1件: 63 💬 |
98 |
Immunoglobulin |
- |
- |
- |
- |
013 3件: 13, 14, 63 💬 |
99 |
Immunoglobulin g |
- |
- |
- |
- |
011 7件: 11, 13, 14, 49, 50, 63, 65 💬 |
100 |
Inactivated trivalent influenza vaccine |
- |
- |
- |
- |
063 1件: 63 💬 |
101 |
Interleukin 2 |
- |
- |
- |
- |
046 9件: 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
102 |
Ivig-l |
- |
- |
- |
- |
063 1件: 63 💬 |
103 |
Lansoprazole |
Lansoprazole |
1件: D00355 D00355 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 7件: 63, 71, 85, 98, 166, 222, 299 💬 |
104 |
Lansoprazole, clarithromycin, amoxycillin |
Amoxicillin |
5件: D00229 D00229, D00276 D00276, D00355 D00355, D02925 D02925, D07452 D07452 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 1件: 63 💬 |
105 |
Liv-gamma sn inj. |
- |
- |
- |
- |
063 1件: 63 💬 |
106 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
107 |
Medical standard of care for itp |
- |
- |
- |
- |
063 1件: 63 💬 |
108 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
109 |
Metronidazole |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 8件: 46, 51, 63, 94, 95, 96, 97, 291 💬 |
110 |
Nanogam |
- |
- |
- |
- |
063 1件: 63 💬 |
111 |
Newgam |
- |
- |
- |
- |
014 3件: 14, 63, 65 💬 |
112 |
Nplate |
- |
- |
- |
- |
063 1件: 63 💬 |
113 |
Nplate 500 microgramos polvo para solución inyectable |
- |
- |
- |
- |
063 1件: 63 💬 |
114 |
Null |
- |
- |
- |
- |
006 16件: 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
115 |
Octagam 10% |
- |
- |
- |
- |
050 3件: 50, 63, 65 💬 |
116 |
Octagam® 10% |
- |
- |
- |
- |
063 1件: 63 💬 |
117 |
Open label (avatrombopag tablets) |
Avatrombopag |
1件: D10306 D10306 💬 |
- |
- |
063 1件: 63 💬 |
118 |
Other: healthy controls |
- |
- |
- |
- |
063 1件: 63 💬 |
119 |
Other: rp% measurement by fcm as a diagnostic test for itp |
- |
- |
- |
- |
063 1件: 63 💬 |
120 |
Palmitate |
Palmitic Acid |
1件: D05341 D05341 💬 |
- |
- |
063 1件: 63 💬 |
121 |
Pf-06755347 intravenous |
- |
- |
- |
- |
063 1件: 63 💬 |
122 |
Pf-06755347 subcutaneous |
- |
- |
- |
- |
063 1件: 63 💬 |
123 |
Pg2 |
- |
- |
- |
- |
063 1件: 63 💬 |
124 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
125 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
126 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
127 |
Privigen® |
- |
- |
- |
- |
014 3件: 14, 63, 65 💬 |
128 |
Promacta |
- |
- |
- |
- |
063 2件: 63, 65 💬 |
129 |
Proteína recombinante estimulante de la megacariopoyesis |
- |
- |
- |
- |
063 1件: 63 💬 |
130 |
Prtx-100 (staphylococcal protein a) |
Bevifimod |
- |
- |
- |
063 1件: 63 💬 |
131 |
R788 |
- |
- |
- |
- |
046 2件: 46, 63 💬 |
132 |
Recombinant human thrombopoietin |
Recombinant Human Thrombopoietin |
- |
- |
- |
063 1件: 63 💬 |
133 |
Recombinant human thrombopoietin (rh-tpo) |
Recombinant Human Thrombopoietin |
- |
- |
- |
063 1件: 63 💬 |
134 |
Recombinant human thrombopoietin (rhtpo) |
Recombinant Human Thrombopoietin |
- |
- |
- |
063 1件: 63 💬 |
135 |
Relovade |
- |
- |
- |
- |
063 1件: 63 💬 |
136 |
Revolade |
- |
- |
- |
- |
060 2件: 60, 63 💬 |
137 |
Revolade 25 mg film-coated tablets |
- |
- |
- |
- |
063 1件: 63 💬 |
138 |
Revolade 50 mg film-coated tablets |
- |
- |
- |
- |
063 1件: 63 💬 |
139 |
Revolade, promacta |
- |
- |
- |
- |
063 1件: 63 💬 |
140 |
Rhtpo |
Recombinant Human Thrombopoietin |
- |
- |
- |
060 2件: 60, 63 💬 |
141 |
Rhtpo in combination with rituximab |
Recombinant Human Thrombopoietin |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
063 1件: 63 💬 |
142 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
143 |
Rituximab [mabthera/rituxan] |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
046 2件: 46, 63 💬 |
144 |
Romiplostim |
Romiplostim |
1件: D08990 D08990 💬 |
MPL 1件: MPL 💬 |
Cytokine-cytokine receptor interaction 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway |
060 4件: 60, 63, 64, 65 💬 |
145 |
Romiplostin |
- |
- |
- |
- |
063 1件: 63 💬 |
146 |
Rozanolixizumab |
Rozanolixizumab |
- |
- |
- |
011 3件: 11, 14, 63 💬 |
147 |
Sb-497115 |
- |
- |
- |
- |
063 1件: 63 💬 |
148 |
Sb-497115-gr |
- |
- |
- |
- |
063 1件: 63 💬 |
149 |
Sb-497115-gr 12.5mg |
- |
- |
- |
- |
063 1件: 63 💬 |
150 |
Sb-497115-gr 25mg |
- |
- |
- |
- |
063 1件: 63 💬 |
151 |
Sb-497115-gr 50 mg |
- |
- |
- |
- |
063 1件: 63 💬 |
152 |
Sb497115 |
- |
- |
- |
- |
060 2件: 60, 63 💬 |
153 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
154 |
Sm101 |
- |
- |
- |
- |
049 3件: 49, 63, 66 💬 |
155 |
Sm101 20mg/ml |
- |
- |
- |
- |
063 1件: 63 💬 |
156 |
Sm101 5mg/ml |
- |
- |
- |
- |
063 1件: 63 💬 |
157 |
Standard of care |
- |
- |
- |
- |
006 12件: 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
158 |
Staphylococcal protein a |
Bevifimod |
- |
- |
- |
063 1件: 63 💬 |
159 |
Steroids |
- |
- |
- |
- |
046 7件: 46, 50, 51, 63, 66, 96, 97 💬 |
160 |
Tak-079 |
- |
- |
- |
- |
011 3件: 11, 49, 63 💬 |
161 |
Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) |
Amoxicillin |
7件: D00229 D00229, D00276 D00276, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
063 1件: 63 💬 |
162 |
Thrombopoietin |
Thrombopoietin |
- |
- |
- |
047 3件: 47, 60, 63 💬 |
163 |
Tpo |
- |
- |
- |
- |
063 1件: 63 💬 |
164 |
Triple therapy |
- |
- |
- |
- |
063 1件: 63 💬 |
165 |
Tysabri |
- |
- |
- |
- |
013 3件: 13, 25, 63 💬 |
166 |
Ucb7665 |
- |
- |
- |
- |
011 3件: 11, 14, 63 💬 |
167 |
Vonoprazan |
Vonoprazan |
1件: D11784 D11784 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 2件: 63, 98 💬 |
168 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |